Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The association between low vitamin D and depressive disorders

Molecular Psychiatry volume 19, pages 444–451 (2014)Cite this article

Subjects

Abstract

It has been hypothesized that hypovitaminosis D is associated with depression but epidemiological evidence is limited. We investigated the association between depressive disorders and related clinical characteristics with blood concentrations of 25-hydroxyvitamin D [25(OH)D] in a large cohort. The sample consisted of participants (aged 18–65 years) from the Netherlands Study of Depression and Anxiety (NESDA) with a current (N=1102) or remitted (N=790) depressive disorder (major depressive disorder, dysthymia) defined according to DSM-IV criteria, and healthy controls (N=494). Serum levels of 25(OH)D measured and analyzed in multivariate analyses adjusting for sociodemographics, sunlight, urbanization, lifestyle and health. Of the sample, 33.6% had deficient or insufficient serum 25(OH)D (<50 nmol l−1). As compared with controls, lower 25(OH)D levels were found in participants with current depression (P=0.001, Cohen’s d=0.21), particularly in those with the most severe symptoms (P=0.001, Cohen’s d=0.44). In currently depressed persons, 25(OH)D was inversely associated with symptom severity (β=−0.19, s.e.=0.07, P=0.003) suggesting a dose-response gradient, and with risk (relative risk=0.90, 95% confidence interval=0.82–0.99, P=0.03) of having a depressive disorders at 2-year follow-up. This large cohort study indicates that low levels of 25(OH)D were associated to the presence and severity of depressive disorder suggesting that hypovitaminosis D may represent an underlying biological vulnerability for depression. Future studies should elucidate whether—the highly prevalent—hypovitaminosis D could be cost-effectively treated as part of preventive or treatment interventions for depression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Murray CJ, Lopez AD . Alternative projections of mortality and disability by cause 1990 2020: Global Burden of Disease Study. Lancet 1997; 349: 1498–1504.

    Article  CAS  Google Scholar 

  2. Cuijpers P, Beekman AT, Reynolds CF . III. Preventing depression: a global priority. JAMA 2012; 307: 1033–1034.

    Article  CAS  Google Scholar 

  3. Annweiler C, Allali G, Allain P, Bridenbaugh S, Schott AM, Kressig RW et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 2009; 16: 1083–1089.

    Article  CAS  Google Scholar 

  4. Cherniack EP, Troen BR, Florez HJ, Roos BA, Levis S . Some new food for thought: the role of vitamin D in the mental health of older adults. Curr Psychiatry Rep 2009; 11: 12–19.

    Article  Google Scholar 

  5. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ . Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005; 29: 21–30.

    Article  CAS  Google Scholar 

  6. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM et al. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001; 86: 888–894.

    CAS  PubMed  Google Scholar 

  7. Neveu I, Naveilhan P, Jehan F, Baudet C, Wion D, De Luca HF et al. 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res 1994; 24: 70–76.

    Article  CAS  Google Scholar 

  8. Neveu I, Naveilhan P, Baudet C, Brachet P, Metsis M . 1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 1994; 30: 124–126.

    Article  Google Scholar 

  9. McCann JC, Ames BN . Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 2008; 22: 982–1001.

    Article  CAS  Google Scholar 

  10. Alroy I, Towers TL, Freedman LP . Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 1995; 15: 5789–5799.

    Article  CAS  Google Scholar 

  11. Sun J, Kong J, Duan Y, Szeto FL, Liao A, Madara JL et al. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor. Am J Physiol Endocrinol Metab 2006; 291: E315–E322.

    Article  CAS  Google Scholar 

  12. Howren MB, Lamkin DM, Suls J . Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171–186.

    Article  CAS  Google Scholar 

  13. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446–457.

    Article  CAS  Google Scholar 

  14. Parker G, Brotchie H . 'D' for depression: any role for vitamin D? 'Food for Thought' II. Acta Psychiatr Scand 2011; 124: 243–249.

    Article  CAS  Google Scholar 

  15. Bertone-Johnson ER . Vitamin D and the occurrence of depression: causal association or circumstantial evidence? Nutr Rev 2009; 67: 481–492.

    Article  Google Scholar 

  16. Hoogendijk WJ, Lips P, Dik MG, Deeg DJ, Beekman AT, Penninx BW . Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch Gen Psychiatry 2008; 65: 508–512.

    Article  CAS  Google Scholar 

  17. Milaneschi Y, Shardell M, Corsi AM, Vazzana R, Bandinelli S, Guralnik JM et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J Clin Endocrinol Metab 2010; 95: 3225–3233.

    Article  CAS  Google Scholar 

  18. Bertone-Johnson ER, Powers SI, Spangler L, Brunner RL, Michael YL, Larson JC et al. Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women. Am J Clin Nutr 2011; 94: 1104–1112.

    Article  CAS  Google Scholar 

  19. Ganji V, Milone C, Cody MM, McCarty F, Wang YT . Serum vitamin D concentrations are related to depression in young adult US population: the Third National Health and Nutrition Examination Survey. Int Arch Med 2010; 3: 29–36.

    Article  Google Scholar 

  20. May HT, Bair TL, Lappé DL . Association of vitamin D levels with incident depression among a general cardiovascular population. Am Heart J 2010; 159: 1037–1043.

    Article  CAS  Google Scholar 

  21. Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008; 17: 121–140.

    Article  Google Scholar 

  22. Lamers F, Hoogendoorn AW, Smit JH, Van DR, Zitman FG, Nolen WA et al2012 Sociodemographic and psychiatric determinants of attrition in the Netherlands Study of Depression and Anxiety (NESDA). Compr Psychiatry 53: 63–70.

    Article  Google Scholar 

  23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn American Psychiatric Association: Washington, DC, USA, 2001.

  24. World Health Organization. The Composite Interview Diagnostic Instrument (CIDI). WHO: Geneva, Switzerland, 1997.

  25. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH . The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996; 26: 477–486.

    Article  CAS  Google Scholar 

  26. Heijboer AC, Blankenstein MA, Kema IP, Buijs MM . Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012; 58: 543–548.

    Article  CAS  Google Scholar 

  27. Carter GD . 25-hydroxyvitamin D: a difficult analyte. Clin Chem 2012; 58: 486–488.

    Article  CAS  Google Scholar 

  28. Ross AC, Manson JE, Abrams SA et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53–58.

    Article  CAS  Google Scholar 

  29. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911–1930.

    Article  CAS  Google Scholar 

  30. Lyketsos CG, Nestadt G, Cwi J, Heithoff K, Eaton WW . The life chart interview: a standardized method to describe the course of psychopathology. Int J Methods Psychiatr Res 2012; 4: 143–155.

    Google Scholar 

  31. WHO. Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical Classification. WHO: Geneva, Switzerland, 2007.

  32. Babor TF, Fuente JRD, Saunders J, Grant M . The alcohol use disorders identification test: guidelines for use in primary health care. WHO: Geneva, Switzerland, 1992.

    Google Scholar 

  33. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 1381–1395.

    Article  Google Scholar 

  34. Cockcroft DW, Gault MH . Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41.

    Article  CAS  Google Scholar 

  35. Snijder MB, van Dam RM, Visser M, Deeg DJ, Dekker JM, Bouter LM et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab 2005; 90: 4119–4123.

    Article  CAS  Google Scholar 

  36. Cohen J . Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum Associates: Hillsdale, NJ, USA, 1988.

    Google Scholar 

  37. Zou G . A Modified Poisson Regression Approach to Prospective Studies with Binary Data. Am J Epidemiol 2004; 159: 702–706.

    Article  Google Scholar 

  38. McNutt LA, Wu C, Xue X, Hafner P . Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes. Am J Epidemiol 2003; 157: 940–943.

    Article  Google Scholar 

  39. Cohen AC . Truncated and Censored Samples: Theory and Applications. Marcel Dekker: New York, NY, USA, 1991.

    Book  Google Scholar 

  40. Molendijk ML, Bus BA, Spinhoven P, BWJH Penninx, Kenis G, Prickaerts J et al. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 2011; 16: 1088–1095.

    Article  CAS  Google Scholar 

  41. Vreeburg SA, Hoogendijk WJ, van Pelt J, DeRijk RH, Verhagen JCM et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 2009; 66: 617–626.

    Article  CAS  Google Scholar 

  42. Lips P . Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477–501.

    Article  CAS  Google Scholar 

  43. Lips P . Vitamin D physiology. Prog Biophys Mol Biol 2006; 92: 4–8.

    Article  CAS  Google Scholar 

  44. Petronijevic M, Petronijevic N, Ivkovic M, Stefanovic D, Radonjic D, Glisic B et al. Low bone mineral density and high bone metabolism turnover in premenopausal women with unipolar depression. Bone 2008; 42: 582–590.

    Article  CAS  Google Scholar 

  45. Saunders BD, Saunders EF, Gauger PG . Lithium therapy and hyperparathyroidism: an evidence-based assessment. World J Surg 2009; 33: 2314–2323.

    Article  Google Scholar 

  46. Haney EM, Chan BKS, Diem SJ, Ensrud KE, Cauley JA et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 2007; 167: 1246–1251.

    Article  Google Scholar 

  47. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007; 167: 188–194.

    Article  CAS  Google Scholar 

  48. Ziere G, Dieleman JP, van der Cammen TJ, Hofman A, Pols HA, Stricker BH . Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol 2008; 28: 411–417.

    Article  CAS  Google Scholar 

  49. Millen AE, Wactawski-Wende J, Pettinger M, Melamed ML, Tylavsky FA, Liu S . Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D clinical trial. Am J Clin Nutr 2010; 91: 1324–1335.

    Article  CAS  Google Scholar 

  50. van Dam RM, Snijder MB, Dekker JM, Stehouwer CD, Bouter LM, Heine RJ et al. Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study. Am J Clin Nutr 2007; 85: 755–761.

    Article  CAS  Google Scholar 

  51. van Gool CH, Kempen GI, Penninx BW, Deeg DJ, Beekman AT, van Eijk JT . Relationship between changes in depressive symptoms and unhealthy lifestyles in late middle aged and older persons: results from the Longitudinal Aging Study Amsterdam. Age Ageing 2003; 32: 81–87.

    Article  Google Scholar 

  52. Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220–229.

    Article  Google Scholar 

  53. Holick MF . Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80: 1678S–1688SS.

    Article  CAS  Google Scholar 

  54. Yetley EA . Assessing the vitamin D status of the US population. Am J Clin Nutr 2008; 88: 558S–564S.

    Article  CAS  Google Scholar 

  55. Jorde R, Sneve M, Figenschau Y, Svartberg J, Waterloo K . Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern Med 2008; 264: 599–609.

    Article  CAS  Google Scholar 

  56. Bertone-Johnson ER, Powers SI, Spangler L, Larson J, Michael YL, Millen AE et al. Vitamin D supplementation and depression in the women's health initiative calcium and vitamin D trial. Am J Epidemiol 2012; 176: 1–13.

    Article  Google Scholar 

  57. Kjaergaard M, Waterloo K, Wang CE, Almas B, Figenschau Y, Hutchinson MS et al. Effect of vitamin D supplement on depression scores in people with low levels of serum 25-hydroxyvitamin D: nested case-control study and randomised clinical trial. Br J Psychiatry 2012; 201: 360–368.

    Article  Google Scholar 

Download references

Acknowledgements

The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organization for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Institute for Quality of Health Care (IQ Healthcare), Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos). Assaying of vitamin D and PTH was supported by the Neuroscience Campus Amsterdam and the Dutch Brain Foundation.

Author information

Authors and Affiliations

  1. Department of Psychiatry, and EMGO Institute for Health and Care Research and Neuroscience Campus Amsterdam, VU University Medical Center/GGZ inGeest, Amsterdam, The Netherlands

    Y Milaneschi, A T F Beekman, J H Smit & B W J H Penninx

  2. Department of Psychiatry, Erasmus Medical Center, Rotterdam, The Netherlands

    W Hoogendijk

  3. Department of Internal Medicine, Endocrine Section, VU University Medical Center, Amsterdam, The Netherlands

    P Lips

  4. Department of Clinical Chemistry, VU University Medical Center, The Netherlands

    A C Heijboer

  5. Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands

    R Schoevers & B W J H Penninx

  6. Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands

    A M van Hemert & B W J H Penninx

Authors
  1. Y Milaneschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W Hoogendijk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Lips
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A C Heijboer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Schoevers
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A M van Hemert
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A T F Beekman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J H Smit
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B W J H Penninx
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y Milaneschi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Molecular Psychiatry website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milaneschi, Y., Hoogendijk, W., Lips, P. et al. The association between low vitamin D and depressive disorders. Mol Psychiatry 19, 444–451 (2014). https://doi.org/10.1038/mp.2013.36

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/mp.2013.36

Keywords

Search

Advanced search

Quick links